Usona in the News
Chasing Life with Dr. Sanjay Gupta: Treating the Depressed Brain featuring Dr. Charles Raison (Podcast)
As the use of antidepressants have steadily risen since their introduction in the 1980s, what have we learned about depression?
November 14, 2023 | CNN
What Does Good Psychedelic Therapy Look Like?
As MDMA and psilocybin treatments become more mainstream, the therapy component has come under scrutiny. Here’s what’s common in many sessions...
June 3, 2023 | New York Times
When nothing else works
Could psychoactive substances like psilocybin, MDMA and ketamine finally crack the code on treatment-resistant depression, anxiety or PTSD?
May 2, 2023 | Madison Magazine
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry
In the nascent industry of medical psychedelics, drug development is the name of the game.
June 2, 2022 | Business Insider
Psychedelic-assisted psychotherapy shakes off an old stigma
In the 1960s, the US limited research on psychedelics. Now, these once taboo substances are being recognized for their full medical potential.
March 16, 2022 | National Association of Science Writers
Parting the Clouds
Charles Raison On New Treatments For Depression
January 29, 2021 | The Sun MagazineUpdates
Usona Statement on Phase 3 Study of Psilocybin for Major Depressive Disorder (MDD) (uAspire)
March 20, 2024
Usona Institute Research Unveils New Compounds with Observed Psychedelic-like Activity
January 10, 2024
Usona statement on JAMA publication of PSIL201 data
August 31, 2023
Media Inquiries
MEDIA REQUESTMedia Inquiries
Please contact mediarequests@usonainstitute.org with the following information:
- Name and organization
- Description of what you would like to cover
- Deadline